Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2021

Publisher Name :
Date: 18-Jan-2021
No. of pages: 138
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Emergency Vaccines

- Conventional Vaccines

Segment by Application

- Cattle

- Pig

- Sheep & Goat

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Jinyu Group

- Cavet Bio

- Indian Immunologicals

- Tecon Group

- CAHIC

- Shen Lian

- Biogenesis Bagó

- BIGVET Biotech

- Boehringer Ingelheim

- MSD Animal Health

- CEVA

- FGBI

- Bayer HealthCare

- Brilliant Bio Pharma

- VECOL

- Sanofi (Merial)

- VETAL

- BVI

- LIMOR

- ME VAC

- Agrovet

Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2021

Table of Contents
1 Foot and Mouth Disease (FMD) Vaccines Market Overview
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines
1.2 Foot and Mouth Disease (FMD) Vaccines Segment by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Emergency Vaccines
1.2.3 Conventional Vaccines
1.3 Foot and Mouth Disease (FMD) Vaccines Segment by Application
1.3.1 Foot and Mouth Disease (FMD) Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Cattle
1.3.3 Pig
1.3.4 Sheep & Goat
1.3.5 Others
1.4 Global Foot and Mouth Disease (FMD) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue 2016-2027
1.4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales 2016-2027
1.4.3 Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Foot and Mouth Disease (FMD) Vaccines Market Competition by Manufacturers
2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation and Trends
2.5.1 Foot and Mouth Disease (FMD) Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue
2.5.3 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario by Region
3.1 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country
3.3.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.4.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country
3.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region
3.5.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.6.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country
3.6.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country
3.7.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Analysis by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2016-2021)
5 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Analysis by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Jinyu Group
6.1.1 Jinyu Group Corporation Information
6.1.2 Jinyu Group Description and Business Overview
6.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Jinyu Group Product Portfolio
6.1.5 Jinyu Group Recent Developments/Updates
6.2 Cavet Bio
6.2.1 Cavet Bio Corporation Information
6.2.2 Cavet Bio Description and Business Overview
6.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Cavet Bio Product Portfolio
6.2.5 Cavet Bio Recent Developments/Updates
6.3 Indian Immunologicals
6.3.1 Indian Immunologicals Corporation Information
6.3.2 Indian Immunologicals Description and Business Overview
6.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Indian Immunologicals Product Portfolio
6.3.5 Indian Immunologicals Recent Developments/Updates
6.4 Tecon Group
6.4.1 Tecon Group Corporation Information
6.4.2 Tecon Group Description and Business Overview
6.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Tecon Group Product Portfolio
6.4.5 Tecon Group Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 CAHIC Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 Shen Lian
6.6.1 Shen Lian Corporation Information
6.6.2 Shen Lian Description and Business Overview
6.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Shen Lian Product Portfolio
6.6.5 Shen Lian Recent Developments/Updates
6.7 Biogenesis Bagó
6.6.1 Biogenesis Bagó Corporation Information
6.6.2 Biogenesis Bagó Description and Business Overview
6.6.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biogenesis Bagó Product Portfolio
6.7.5 Biogenesis Bagó Recent Developments/Updates
6.8 BIGVET Biotech
6.8.1 BIGVET Biotech Corporation Information
6.8.2 BIGVET Biotech Description and Business Overview
6.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BIGVET Biotech Product Portfolio
6.8.5 BIGVET Biotech Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Boehringer Ingelheim Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 MSD Animal Health
6.10.1 MSD Animal Health Corporation Information
6.10.2 MSD Animal Health Description and Business Overview
6.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 MSD Animal Health Product Portfolio
6.10.5 MSD Animal Health Recent Developments/Updates
6.11 CEVA
6.11.1 CEVA Corporation Information
6.11.2 CEVA Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 CEVA Product Portfolio
6.11.5 CEVA Recent Developments/Updates
6.12 FGBI
6.12.1 FGBI Corporation Information
6.12.2 FGBI Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 FGBI Product Portfolio
6.12.5 FGBI Recent Developments/Updates
6.13 Bayer HealthCare
6.13.1 Bayer HealthCare Corporation Information
6.13.2 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Bayer HealthCare Product Portfolio
6.13.5 Bayer HealthCare Recent Developments/Updates
6.14 Brilliant Bio Pharma
6.14.1 Brilliant Bio Pharma Corporation Information
6.14.2 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Brilliant Bio Pharma Product Portfolio
6.14.5 Brilliant Bio Pharma Recent Developments/Updates
6.15 VECOL
6.15.1 VECOL Corporation Information
6.15.2 VECOL Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 VECOL Product Portfolio
6.15.5 VECOL Recent Developments/Updates
6.16 Sanofi (Merial)
6.16.1 Sanofi (Merial) Corporation Information
6.16.2 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Sanofi (Merial) Product Portfolio
6.16.5 Sanofi (Merial) Recent Developments/Updates
6.17 VETAL
6.17.1 VETAL Corporation Information
6.17.2 VETAL Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.17.4 VETAL Product Portfolio
6.17.5 VETAL Recent Developments/Updates
6.18 BVI
6.18.1 BVI Corporation Information
6.18.2 BVI Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.18.4 BVI Product Portfolio
6.18.5 BVI Recent Developments/Updates
6.19 LIMOR
6.19.1 LIMOR Corporation Information
6.19.2 LIMOR Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.19.4 LIMOR Product Portfolio
6.19.5 LIMOR Recent Developments/Updates
6.20 ME VAC
6.20.1 ME VAC Corporation Information
6.20.2 ME VAC Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.20.4 ME VAC Product Portfolio
6.20.5 ME VAC Recent Developments/Updates
6.21 Agrovet
6.21.1 Agrovet Corporation Information
6.21.2 Agrovet Foot and Mouth Disease (FMD) Vaccines Description and Business Overview
6.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Agrovet Product Portfolio
6.21.5 Agrovet Recent Developments/Updates
7 Foot and Mouth Disease (FMD) Vaccines Manufacturing Cost Analysis
7.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
7.4 Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Foot and Mouth Disease (FMD) Vaccines Distributors List
8.3 Foot and Mouth Disease (FMD) Vaccines Customers
9 Foot and Mouth Disease (FMD) Vaccines Market Dynamics
9.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
9.2 Foot and Mouth Disease (FMD) Vaccines Growth Drivers
9.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges
9.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints
10 Global Market Forecast
10.1 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Foot and Mouth Disease (FMD) Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Foot and Mouth Disease (FMD) Vaccines by Type (2022-2027)
10.2 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Foot and Mouth Disease (FMD) Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Foot and Mouth Disease (FMD) Vaccines by Application (2022-2027)
10.3 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Foot and Mouth Disease (FMD) Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Foot and Mouth Disease (FMD) Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) Comparison by Application (2021-2027)
Table 3. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Covered in This Study
Table 5. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) of Key Manufacturers (2016-2021)
Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Foot and Mouth Disease (FMD) Vaccines Average Price (USD/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
Table 12. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L)
Table 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 19. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 23. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L)
Table 27. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 31. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 35. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2016-2021)
Table 39. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Foot and Mouth Disease (FMD) Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Type (2016-2021)
Table 43. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2016-2021)
Table 44. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Foot and Mouth Disease (FMD) Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Application (2016-2021)
Table 48. Jinyu Group Corporation Information
Table 49. Jinyu Group Description and Business Overview
Table 50. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 51. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product
Table 52. Jinyu Group Recent Developments/Updates
Table 53. Cavet Bio Corporation Information
Table 54. Cavet Bio Description and Business Overview
Table 55. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 56. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product
Table 57. Cavet Bio Recent Developments/Updates
Table 58. Indian Immunologicals Corporation Information
Table 59. Indian Immunologicals Description and Business Overview
Table 60. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 61. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product
Table 62. Indian Immunologicals Recent Developments/Updates
Table 63. Tecon Group Corporation Information
Table 64. Tecon Group Description and Business Overview
Table 65. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 66. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product
Table 67. Tecon Group Recent Developments/Updates
Table 68. CAHIC Corporation Information
Table 69. CAHIC Description and Business Overview
Table 70. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 71. CAHIC Foot and Mouth Disease (FMD) Vaccines Product
Table 72. CAHIC Recent Developments/Updates
Table 73. Shen Lian Corporation Information
Table 74. Shen Lian Description and Business Overview
Table 75. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 76. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product
Table 77. Shen Lian Recent Developments/Updates
Table 78. Biogenesis Bagó Corporation Information
Table 79. Biogenesis Bagó Description and Business Overview
Table 80. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 81. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product
Table 82. Biogenesis Bagó Recent Developments/Updates
Table 83. BIGVET Biotech Corporation Information
Table 84. BIGVET Biotech Description and Business Overview
Table 85. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 86. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product
Table 87. BIGVET Biotech Recent Developments/Updates
Table 88. Boehringer Ingelheim Corporation Information
Table 89. Boehringer Ingelheim Description and Business Overview
Table 90. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 91. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product
Table 92. Boehringer Ingelheim Recent Developments/Updates
Table 93. MSD Animal Health Corporation Information
Table 94. MSD Animal Health Description and Business Overview
Table 95. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 96. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product
Table 97. MSD Animal Health Recent Developments/Updates
Table 98. CEVA Corporation Information
Table 99. CEVA Description and Business Overview
Table 100. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 101. CEVA Foot and Mouth Disease (FMD) Vaccines Product
Table 102. CEVA Recent Developments/Updates
Table 103. FGBI Corporation Information
Table 104. FGBI Description and Business Overview
Table 105. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 106. FGBI Foot and Mouth Disease (FMD) Vaccines Product
Table 107. FGBI Recent Developments/Updates
Table 108. Bayer HealthCare Corporation Information
Table 109. Bayer HealthCare Description and Business Overview
Table 110. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 111. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product
Table 112. Bayer HealthCare Recent Developments/Updates
Table 113. Brilliant Bio Pharma Corporation Information
Table 114. Brilliant Bio Pharma Description and Business Overview
Table 115. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 116. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product
Table 117. Brilliant Bio Pharma Recent Developments/Updates
Table 118. VECOL Corporation Information
Table 119. VECOL Description and Business Overview
Table 120. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 121. VECOL Foot and Mouth Disease (FMD) Vaccines Product
Table 122. VECOL Recent Developments/Updates
Table 123. Sanofi (Merial) Corporation Information
Table 124. Sanofi (Merial) Description and Business Overview
Table 125. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 126. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product
Table 127. Sanofi (Merial) Recent Developments/Updates
Table 128. VETAL Corporation Information
Table 129. VETAL Description and Business Overview
Table 130. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 131. VETAL Foot and Mouth Disease (FMD) Vaccines Product
Table 132. VETAL Recent Developments/Updates
Table 133. BVI Corporation Information
Table 134. BVI Description and Business Overview
Table 135. BVI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 136. BVI Foot and Mouth Disease (FMD) Vaccines Product
Table 137. BVI Recent Developments/Updates
Table 138. LIMOR Corporation Information
Table 139. LIMOR Description and Business Overview
Table 140. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 141. LIMOR Foot and Mouth Disease (FMD) Vaccines Product
Table 142. LIMOR Recent Developments/Updates
Table 143. ME VAC Corporation Information
Table 144. ME VAC Description and Business Overview
Table 145. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 146. ME VAC Foot and Mouth Disease (FMD) Vaccines Product
Table 147. ME VAC Recent Developments/Updates
Table 148. Agrovet Corporation Information
Table 149. Agrovet Description and Business Overview
Table 150. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 151. Agrovet Foot and Mouth Disease (FMD) Vaccines Product
Table 152. Agrovet Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Foot and Mouth Disease (FMD) Vaccines Distributors List
Table 156. Foot and Mouth Disease (FMD) Vaccines Customers List
Table 157. Foot and Mouth Disease (FMD) Vaccines Market Trends
Table 158. Foot and Mouth Disease (FMD) Vaccines Growth Drivers
Table 159. Foot and Mouth Disease (FMD) Vaccines Market Restraints
Table 160. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2022-2027) & (K L)
Table 161. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 162. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 163. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 164. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2022-2027) & (K L)
Table 165. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 166. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 167. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 168. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Region (2022-2027) & (K L)
Table 169. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 170. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 171. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Foot and Mouth Disease (FMD) Vaccines
Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Type in 2020 & 2027
Figure 3. Emergency Vaccines Product Picture
Figure 4. Conventional Vaccines Product Picture
Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Application in 2020 & 2027
Figure 6. Cattle
Figure 7. Pig
Figure 8. Sheep & Goat
Figure 9. Others
Figure 10. Global Foot and Mouth Disease (FMD) Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Foot and Mouth Disease (FMD) Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Sales 2016-2027 (K L)
Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturers in 2020
Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Foot and Mouth Disease (FMD) Vaccines Players: Market Share by Revenue in 2020
Figure 17. Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
Figure 19. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region in 2020
Figure 20. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2016-2021)
Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region in 2020
Figure 22. U.S. Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Type (2016-2021)
Figure 47. Sales Market Share of Foot and M
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs